Microsaic Appoint New Chief Executive Officer
News Sep 25, 2012
Colin has nearly 30 years commercial and operational experience in the analytical instrumentation sector. He joins Microsaic from Shimadzu UK Ltd, a global manufacturer of scientific research instruments, where he spent the past 11 years as Managing Director. He was previously European Commercial Director at SGE Europe Ltd (1999-2001) and prior to that, he spent seven years in senior management and marketing positions at Mallinckrodt Baker in the UK and the Netherlands. Between 1983 and 1991 Colin served in sales and marketing positions at Bayer Diagnostics, Roche Diagnostics and Wellcome Diagnostics.
Colin will take up his role on 5th November 2012, at which point Eric Yeatman and Colin Nicholl will resume their former roles as Chairman and Deputy Chairman, respectively. The Board would like to acknowledge the roles both Eric and Colin have played over the past year in establishing the strong position for growth that the Company is in and look forward to their continued contributions in their Board capacities.
Commenting on the appointment, Eric Yeatman, Acting Chief Executive of Microsaic Systems plc, said:
“The Board is very pleased to welcome Colin Jump to the Company as our new CEO. I have no doubt his commercial and operational experience in the analytical instrumentation sector will help drive the business forward towards the further realisation of our corporate goals.”
Colin Jump added:
“I am excited to be joining Microsaic Systems at this crucial stage as it accelerates the commercialisation of its revolutionary chip-based technology. With the ability to address major opportunities across multiple market areas I see huge potential for the technology and for the Company in the years ahead.”
Lead and Other Toxic Metals Found in E-Cigarette 'Vapors'News
Significant amounts of toxic metals, including lead, leak from some e-cigarette heating coils and are present in the aerosols inhaled by users, according to a new study.READ MORE
Understanding the Process of Cell DivisionNews
Using multiple techniques such as structural modelling, X-ray scattering, X-ray crystallography and electron microscopy, scientists have found that the Spc110 protein provides a greater function in mitosis originally believed. This information could help understand the process in human cells and the abnormalities that occur in cancer.READ MORE